These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35235153)

  • 21. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica.
    Krämer A; Maloney EM; Morgan OS; Rodgers-Johnson P; Manns A; Murphy EL; Larsen S; Cranston B; Murphy J; Benichou J
    Am J Epidemiol; 1995 Dec; 142(11):1212-20. PubMed ID: 7485068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High incidence of HAM/TSP-like symptoms in WKA rats after administration of human T-cell leukemia virus type 1-producing cells.
    Kushida S; Mizusawa H; Matsumura M; Tanaka H; Ami Y; Hori M; Yagami K; Kameyama T; Tanaka Y; Yoshida A
    J Virol; 1994 Nov; 68(11):7221-6. PubMed ID: 7933104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
    Yamano Y; Sato T
    Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunopathogenesis of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Nakamura T
    Ann Med; 2000 Dec; 32(9):600-7. PubMed ID: 11209967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nagasaka M; Yamagishi M; Yagishita N; Araya N; Kobayashi S; Makiyama J; Kubokawa M; Yamauchi J; Hasegawa D; Coler-Reilly ALG; Tsutsumi S; Uemura Y; Arai A; Takata A; Inoue E; Hasegawa Y; Watanabe T; Suzuki Y; Uchimaru K; Sato T; Yamano Y
    Proc Natl Acad Sci U S A; 2020 May; 117(21):11685-11691. PubMed ID: 32393644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteoporosis in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Schachter D; Cartier L; Borzutzky A
    Bone; 2003 Aug; 33(2):192-6. PubMed ID: 14499352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased osteopontin expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patient cells is associated with IL-17 expression.
    Sarkis S; Belrose G; Peloponese JM; Olindo S; Césaire R; Mesnard JM; Gross A
    J Clin Virol; 2013 Sep; 58(1):295-8. PubMed ID: 23756056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Saito M; Tanaka R; Arishima S; Matsuzaki T; Ishihara S; Tokashiki T; Ohya Y; Takashima H; Umehara F; Izumo S; Tanaka Y
    Retrovirology; 2013 May; 10():51. PubMed ID: 23651542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-dependent cell-mediated cytotoxicity (ADCC) in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Fujihara K; Itoyama Y; Yu F; Kubo C; Goto I
    J Neurol Sci; 1996 Oct; 142(1-2):65-9. PubMed ID: 8902722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease in naïve T cell production due to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development.
    Gomes JAN; da Silva Dias GA; Fujihara S; Yoshikawa GT; Koyama RVL; Sousa RCM; Quaresma JAS; Fuzii HT
    Immunobiology; 2021 Jan; 226(1):152050. PubMed ID: 33338979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spinal cord anteroposterior atrophy in HAM/TSP: Magnetic resonance imaging and neuropathological analyses.
    Taniguchi A; Mochizuki H; Yamashita A; Shiomi K; Asada Y; Nakazato M
    J Neurol Sci; 2017 Oct; 381():135-140. PubMed ID: 28991665
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Enose-Akahata Y; Jacobson S
    Retrovirology; 2019 Nov; 16(1):35. PubMed ID: 31783764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HAM/TSP: association between white matter lesions on magnetic resonance imaging, clinical and cerebrospinal fluid findings.
    Puccioni-Sohler M; Gasparetto E; Cabral-Castro MJ; Slatter C; Vidal CM; Cortes RD; Rosen BR; Mainero C
    Arq Neuropsiquiatr; 2012 Apr; 70(4):246-51. PubMed ID: 22510735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan.
    Tsutsumi S; Sato T; Yagishita N; Yamauchi J; Araya N; Hasegawa D; Nagasaka M; Coler-Reilly ALG; Inoue E; Takata A; Yamano Y
    Orphanet J Rare Dis; 2019 Oct; 14(1):227. PubMed ID: 31639014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient.
    Takeda R; Ishigaki T; Ohno N; Yokoyama K; Kawamata T; Fukuyama T; Araya N; Yamano Y; Uchimaru K; Tojo A
    Int J Hematol; 2020 Jun; 111(6):891-896. PubMed ID: 31930455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.